Search research articles
Contact Us
Filters
Showing results (91-100 of 128) with videos related to
Page
of 13
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 28, 2010
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop
Robert Pirker, Felix J F Herth, Keith M Kerr, et al.
Virchows Archiv : an International Journal of Pathology
|
November 8, 2023
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy
Anna Caliò, Stefano Marletta, Giulio Settanni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2011
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer
Francesca Molinari, Lara Felicioni, Michela Buscarino, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 31, 2009
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer
Emilio Bria, Michele Milella, Isabella Sperduti, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2013
PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapy
Lucia Veronica Cuorvo, Paolo Verderio, Chiara Maura Ciniselli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 23, 2015
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors
Sara Pilotto, Isabella Sperduti, Silvia Novello, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
December 7, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers
Carol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
JCO Precision Oncology
|
February 17, 2022
<i>ROS1</i> Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm
Antonio Marchetti, Massimo Barberis, Alessia Di Lorito, et al.
Critical Reviews in Oncology/Hematology
|
August 9, 2021
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies
Antonio Russo, Lorena Incorvaia, Umberto Malapelle, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 10, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics
Emina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 128) with videos related to
Sort By:
Page
of 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 28, 2010
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop
Robert Pirker, Felix J F Herth, Keith M Kerr, et al.
Virchows Archiv : an International Journal of Pathology
|
November 8, 2023
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy
Anna Caliò, Stefano Marletta, Giulio Settanni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2011
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer
Francesca Molinari, Lara Felicioni, Michela Buscarino, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 31, 2009
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer
Emilio Bria, Michele Milella, Isabella Sperduti, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2013
PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapy
Lucia Veronica Cuorvo, Paolo Verderio, Chiara Maura Ciniselli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 23, 2015
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors
Sara Pilotto, Isabella Sperduti, Silvia Novello, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
December 7, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers
Carol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
JCO Precision Oncology
|
February 17, 2022
<i>ROS1</i> Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm
Antonio Marchetti, Massimo Barberis, Alessia Di Lorito, et al.
Critical Reviews in Oncology/Hematology
|
August 9, 2021
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies
Antonio Russo, Lorena Incorvaia, Umberto Malapelle, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 10, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics
Emina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Page
of 13